Personal stories

Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health. The winner for 2022 is internationally known for his research on the human gut microbiome and its impact on health and disease.

A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.

J&J Impact Ventures, an investment fund within J&J Foundation, is committed to transforming health systemsby not just investing in a technology, service or delivery mechanism, but also the people committed to building trust for their market-driven solutions.

Based in Singapore, SwipeRx has grown into the largest digital pharmacy network across Southeast Asia, with a mobile app enabling pharmacies to operate more efficiently by acquiring supplies directly from the platform. J&J Impact Ventures, a fund within the Johnson & Johnson Foundation, supports SwipeRx in its work connecting over 245,000 pharmacy professionals who together build public health across the region.

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.

Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.

Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.

Delivering real impact that improves health outcomes for underserved communities requires innovators and investors to make their expectations and standards explicit and then to share a sense of accountability to those expectations.